img

Global Tafenoquine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tafenoquine Market Research Report 2024

Tafenoquine is an aminoquinoline that is used in combination with other antimalarials for the prevention of relapse of Plasmodium vivax malaria and by itself as prophylaxis against all species of malaria. Tafenoquine has been linked to low rates of transient and asymptomatic serum enzyme elevations during therapy but has not been associated with instances of clinically apparent acute liver injury.
According to Mr Accuracy reports’s new survey, global Tafenoquine market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tafenoquine market research.
Key manufacturers engaged in the Tafenoquine industry include GlaxoSmithKline Pharmaceuticals (GSK), J & K Scientific LTD, BOC Sciences, WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., Pharmacodia (Beijing) Co.,Ltd, Amadis Chemical Company Limited and Merck, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Tafenoquine were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Tafenoquine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tafenoquine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GlaxoSmithKline Pharmaceuticals (GSK)
J & K Scientific LTD
BOC Sciences
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Pharmacodia (Beijing) Co.,Ltd
Amadis Chemical Company Limited
Merck
Segment by Type
Powder
Pills

Segment by Application


Radical Cure of P.vivax
P. falciparum Treatment
Prevention of Malaria Relapse

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Tafenoquine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Tafenoquine Market Overview
1.1 Product Overview and Scope of Tafenoquine
1.2 Tafenoquine Segment by Type
1.2.1 Global Tafenoquine Market Value Comparison by Type (2024-2034)
1.2.2 Powder
1.2.3 Pills
1.3 Tafenoquine Segment by Application
1.3.1 Global Tafenoquine Market Value by Application: (2024-2034)
1.3.2 Radical Cure of P.vivax
1.3.3 P. falciparum Treatment
1.3.4 Prevention of Malaria Relapse
1.4 Global Tafenoquine Market Size Estimates and Forecasts
1.4.1 Global Tafenoquine Revenue 2018-2034
1.4.2 Global Tafenoquine Sales 2018-2034
1.4.3 Global Tafenoquine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Tafenoquine Market Competition by Manufacturers
2.1 Global Tafenoquine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Tafenoquine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Tafenoquine Average Price by Manufacturers (2018-2023)
2.4 Global Tafenoquine Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Tafenoquine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tafenoquine, Product Type & Application
2.7 Tafenoquine Market Competitive Situation and Trends
2.7.1 Tafenoquine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tafenoquine Players Market Share by Revenue
2.7.3 Global Tafenoquine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tafenoquine Retrospective Market Scenario by Region
3.1 Global Tafenoquine Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Tafenoquine Global Tafenoquine Sales by Region: 2018-2034
3.2.1 Global Tafenoquine Sales by Region: 2018-2023
3.2.2 Global Tafenoquine Sales by Region: 2024-2034
3.3 Global Tafenoquine Global Tafenoquine Revenue by Region: 2018-2034
3.3.1 Global Tafenoquine Revenue by Region: 2018-2023
3.3.2 Global Tafenoquine Revenue by Region: 2024-2034
3.4 North America Tafenoquine Market Facts & Figures by Country
3.4.1 North America Tafenoquine Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Tafenoquine Sales by Country (2018-2034)
3.4.3 North America Tafenoquine Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tafenoquine Market Facts & Figures by Country
3.5.1 Europe Tafenoquine Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Tafenoquine Sales by Country (2018-2034)
3.5.3 Europe Tafenoquine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tafenoquine Market Facts & Figures by Country
3.6.1 Asia Pacific Tafenoquine Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Tafenoquine Sales by Country (2018-2034)
3.6.3 Asia Pacific Tafenoquine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tafenoquine Market Facts & Figures by Country
3.7.1 Latin America Tafenoquine Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Tafenoquine Sales by Country (2018-2034)
3.7.3 Latin America Tafenoquine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tafenoquine Market Facts & Figures by Country
3.8.1 Middle East and Africa Tafenoquine Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Tafenoquine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Tafenoquine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tafenoquine Sales by Type (2018-2034)
4.1.1 Global Tafenoquine Sales by Type (2018-2023)
4.1.2 Global Tafenoquine Sales by Type (2024-2034)
4.1.3 Global Tafenoquine Sales Market Share by Type (2018-2034)
4.2 Global Tafenoquine Revenue by Type (2018-2034)
4.2.1 Global Tafenoquine Revenue by Type (2018-2023)
4.2.2 Global Tafenoquine Revenue by Type (2024-2034)
4.2.3 Global Tafenoquine Revenue Market Share by Type (2018-2034)
4.3 Global Tafenoquine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Tafenoquine Sales by Application (2018-2034)
5.1.1 Global Tafenoquine Sales by Application (2018-2023)
5.1.2 Global Tafenoquine Sales by Application (2024-2034)
5.1.3 Global Tafenoquine Sales Market Share by Application (2018-2034)
5.2 Global Tafenoquine Revenue by Application (2018-2034)
5.2.1 Global Tafenoquine Revenue by Application (2018-2023)
5.2.2 Global Tafenoquine Revenue by Application (2024-2034)
5.2.3 Global Tafenoquine Revenue Market Share by Application (2018-2034)
5.3 Global Tafenoquine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 GlaxoSmithKline Pharmaceuticals (GSK)
6.1.1 GlaxoSmithKline Pharmaceuticals (GSK) Corporation Information
6.1.2 GlaxoSmithKline Pharmaceuticals (GSK) Description and Business Overview
6.1.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolio
6.1.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments/Updates
6.2 J & K Scientific LTD
6.2.1 J & K Scientific LTD Corporation Information
6.2.2 J & K Scientific LTD Description and Business Overview
6.2.3 J & K Scientific LTD Tafenoquine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 J & K Scientific LTD Tafenoquine Product Portfolio
6.2.5 J & K Scientific LTD Recent Developments/Updates
6.3 BOC Sciences
6.3.1 BOC Sciences Corporation Information
6.3.2 BOC Sciences Description and Business Overview
6.3.3 BOC Sciences Tafenoquine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BOC Sciences Tafenoquine Product Portfolio
6.3.5 BOC Sciences Recent Developments/Updates
6.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
6.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Corporation Information
6.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Description and Business Overview
6.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolio
6.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments/Updates
6.5 Pharmacodia (Beijing) Co.,Ltd
6.5.1 Pharmacodia (Beijing) Co.,Ltd Corporation Information
6.5.2 Pharmacodia (Beijing) Co.,Ltd Description and Business Overview
6.5.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolio
6.5.5 Pharmacodia (Beijing) Co.,Ltd Recent Developments/Updates
6.6 Amadis Chemical Company Limited
6.6.1 Amadis Chemical Company Limited Corporation Information
6.6.2 Amadis Chemical Company Limited Description and Business Overview
6.6.3 Amadis Chemical Company Limited Tafenoquine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Amadis Chemical Company Limited Tafenoquine Product Portfolio
6.6.5 Amadis Chemical Company Limited Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Tafenoquine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Tafenoquine Product Portfolio
6.7.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tafenoquine Industry Chain Analysis
7.2 Tafenoquine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tafenoquine Production Mode & Process
7.4 Tafenoquine Sales and Marketing
7.4.1 Tafenoquine Sales Channels
7.4.2 Tafenoquine Distributors
7.5 Tafenoquine Customers
8 Tafenoquine Market Dynamics
8.1 Tafenoquine Industry Trends
8.2 Tafenoquine Market Drivers
8.3 Tafenoquine Market Challenges
8.4 Tafenoquine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Tafenoquine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Tafenoquine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Tafenoquine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Tafenoquine Sales (Tons) of Key Manufacturers (2018-2023)
Table 5. Global Tafenoquine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Tafenoquine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Tafenoquine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Tafenoquine Average Price (US$/Gram) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Tafenoquine, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Tafenoquine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tafenoquine, Product Type & Application
Table 12. Global Key Manufacturers of Tafenoquine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tafenoquine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tafenoquine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tafenoquine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Tafenoquine Sales by Region (2018-2023) & (Tons)
Table 18. Global Tafenoquine Sales Market Share by Region (2018-2023)
Table 19. Global Tafenoquine Sales by Region (2024-2034) & (Tons)
Table 20. Global Tafenoquine Sales Market Share by Region (2024-2034)
Table 21. Global Tafenoquine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Tafenoquine Revenue Market Share by Region (2018-2023)
Table 23. Global Tafenoquine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Tafenoquine Revenue Market Share by Region (2024-2034)
Table 25. North America Tafenoquine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Tafenoquine Sales by Country (2018-2023) & (Tons)
Table 27. North America Tafenoquine Sales by Country (2024-2034) & (Tons)
Table 28. North America Tafenoquine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Tafenoquine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Tafenoquine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Tafenoquine Sales by Country (2018-2023) & (Tons)
Table 32. Europe Tafenoquine Sales by Country (2024-2034) & (Tons)
Table 33. Europe Tafenoquine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Tafenoquine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Tafenoquine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Tafenoquine Sales by Region (2018-2023) & (Tons)
Table 37. Asia Pacific Tafenoquine Sales by Region (2024-2034) & (Tons)
Table 38. Asia Pacific Tafenoquine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Tafenoquine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Tafenoquine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Tafenoquine Sales by Country (2018-2023) & (Tons)
Table 42. Latin America Tafenoquine Sales by Country (2024-2034) & (Tons)
Table 43. Latin America Tafenoquine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Tafenoquine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Tafenoquine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Tafenoquine Sales by Country (2018-2023) & (Tons)
Table 47. Middle East & Africa Tafenoquine Sales by Country (2024-2034) & (Tons)
Table 48. Middle East & Africa Tafenoquine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Tafenoquine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Tafenoquine Sales (Tons) by Type (2018-2023)
Table 51. Global Tafenoquine Sales (Tons) by Type (2024-2034)
Table 52. Global Tafenoquine Sales Market Share by Type (2018-2023)
Table 53. Global Tafenoquine Sales Market Share by Type (2024-2034)
Table 54. Global Tafenoquine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Tafenoquine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Tafenoquine Revenue Market Share by Type (2018-2023)
Table 57. Global Tafenoquine Revenue Market Share by Type (2024-2034)
Table 58. Global Tafenoquine Price (US$/Gram) by Type (2018-2023)
Table 59. Global Tafenoquine Price (US$/Gram) by Type (2024-2034)
Table 60. Global Tafenoquine Sales (Tons) by Application (2018-2023)
Table 61. Global Tafenoquine Sales (Tons) by Application (2024-2034)
Table 62. Global Tafenoquine Sales Market Share by Application (2018-2023)
Table 63. Global Tafenoquine Sales Market Share by Application (2024-2034)
Table 64. Global Tafenoquine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Tafenoquine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Tafenoquine Revenue Market Share by Application (2018-2023)
Table 67. Global Tafenoquine Revenue Market Share by Application (2024-2034)
Table 68. Global Tafenoquine Price (US$/Gram) by Application (2018-2023)
Table 69. Global Tafenoquine Price (US$/Gram) by Application (2024-2034)
Table 70. GlaxoSmithKline Pharmaceuticals (GSK) Corporation Information
Table 71. GlaxoSmithKline Pharmaceuticals (GSK) Description and Business Overview
Table 72. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales (Tons), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 73. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product
Table 74. GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments/Updates
Table 75. J & K Scientific LTD Corporation Information
Table 76. J & K Scientific LTD Description and Business Overview
Table 77. J & K Scientific LTD Tafenoquine Sales (Tons), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 78. J & K Scientific LTD Tafenoquine Product
Table 79. J & K Scientific LTD Recent Developments/Updates
Table 80. BOC Sciences Corporation Information
Table 81. BOC Sciences Description and Business Overview
Table 82. BOC Sciences Tafenoquine Sales (Tons), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 83. BOC Sciences Tafenoquine Product
Table 84. BOC Sciences Recent Developments/Updates
Table 85. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Corporation Information
Table 86. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Description and Business Overview
Table 87. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales (Tons), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 88. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product
Table 89. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments/Updates
Table 90. Pharmacodia (Beijing) Co.,Ltd Corporation Information
Table 91. Pharmacodia (Beijing) Co.,Ltd Description and Business Overview
Table 92. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales (Tons), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 93. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product
Table 94. Pharmacodia (Beijing) Co.,Ltd Recent Developments/Updates
Table 95. Amadis Chemical Company Limited Corporation Information
Table 96. Amadis Chemical Company Limited Description and Business Overview
Table 97. Amadis Chemical Company Limited Tafenoquine Sales (Tons), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 98. Amadis Chemical Company Limited Tafenoquine Product
Table 99. Amadis Chemical Company Limited Recent Developments/Updates
Table 100. Merck Corporation Information
Table 101. Merck Description and Business Overview
Table 102. Merck Tafenoquine Sales (Tons), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 103. Merck Tafenoquine Product
Table 104. Merck Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Tafenoquine Distributors List
Table 108. Tafenoquine Customers List
Table 109. Tafenoquine Market Trends
Table 110. Tafenoquine Market Drivers
Table 111. Tafenoquine Market Challenges
Table 112. Tafenoquine Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tafenoquine
Figure 2. Global Tafenoquine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Tafenoquine Market Share by Type in 2024 & 2034
Figure 4. Powder Product Picture
Figure 5. Pills Product Picture
Figure 6. Global Tafenoquine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Tafenoquine Market Share by Application in 2024 & 2034
Figure 8. Radical Cure of P.vivax
Figure 9. P. falciparum Treatment
Figure 10. Prevention of Malaria Relapse
Figure 11. Global Tafenoquine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Tafenoquine Market Size (2018-2034) & (US$ Million)
Figure 13. Global Tafenoquine Sales (2018-2034) & (Tons)
Figure 14. Global Tafenoquine Average Price (US$/Gram) & (2018-2034)
Figure 15. Tafenoquine Report Years Considered
Figure 16. Tafenoquine Sales Share by Manufacturers in 2024
Figure 17. Global Tafenoquine Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Tafenoquine Players: Market Share by Revenue in 2024
Figure 19. Tafenoquine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global Tafenoquine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America Tafenoquine Sales Market Share by Country (2018-2034)
Figure 22. North America Tafenoquine Revenue Market Share by Country (2018-2034)
Figure 23. U.S. Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Tafenoquine Sales Market Share by Country (2018-2034)
Figure 26. Europe Tafenoquine Revenue Market Share by Country (2018-2034)
Figure 27. Germany Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Tafenoquine Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Tafenoquine Revenue Market Share by Region (2018-2034)
Figure 34. China Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Taiwan Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Philippines Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Tafenoquine Sales Market Share by Country (2018-2034)
Figure 45. Latin America Tafenoquine Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Tafenoquine Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Tafenoquine Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. UAE Tafenoquine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Tafenoquine by Type (2018-2034)
Figure 55. Global Revenue Market Share of Tafenoquine by Type (2018-2034)
Figure 56. Global Tafenoquine Price (US$/Gram) by Type (2018-2034)
Figure 57. Global Sales Market Share of Tafenoquine by Application (2018-2034)
Figure 58. Global Revenue Market Share of Tafenoquine by Application (2018-2034)
Figure 59. Global Tafenoquine Price (US$/Gram) by Application (2018-2034)
Figure 60. Tafenoquine Value Chain
Figure 61. Tafenoquine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed